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To evaluate whether green tea consumption provides protection against stomach cancer death, relative risks were calculated
using Cox proportional hazards regression analysis in the Japan Collaborative Study for Evaluation of Cancer Risk, sponsored
by the Ministry of Health and Welfare (JACC Study). The study was based on 30370 men and 42481 women aged 40–79.
After adjustment for age, smoking status, history of peptic ulcer, family history of stomach cancer along with certain dietary
items, the risks associated with drinking one or two, three or four, ﬁve to nine, and 10 or more cups of green tea per day,
relative to those of drinking less than one cup per day, were 1.6 (95% CI: 0.9–2.9), 1.1 (95% CI: 0.6–1.9), 1.0 (95% CI: 0.5–
2.0), and 1.0 (95% CI: 0.5–2.0), respectively, in men (P for trend=0.669), and 1.1 (95% CI: 0.5–2.5), 1.0 (95% CI: 0.5–2.5),
0.8 (95% CI: 0.4–1.6), and 0.8 (95% CI: 0.3–2.1), respectively, in women (P for trend=0.488). We found no inverse
association between green tea consumption and the risk of stomach cancer death.
British Journal of Cancer (2002) 87, 309–313. doi:10.1038/sj.bjc.6600487 www.bjcancer.com
ã 2002 Cancer Research UK
Keywords: green tea; stomach cancer; JACC study
Stomach cancer is still the leading cause of cancer death among
women and the second among men in Japan (Ministry of Health
and Welfare Japan, 2000). It has recently been reported (Setiawan
et al, 2001; Inoue et al, 1998) that the consumption of green tea is
inversely associated with the risk of stomach cancer, that is a
protective effect. Green tea polyphenols have various anticarcino-
genic effects, such as strong antioxidant activity, inhibition of
nitrosation and cell proliferation.
Although case-control studies (Setiawan et al, 2001; Inoue et al,
1998; Ji et al, 1996; Yu et al, 1995; Kono et al, 1988) have found a
reduced risk of stomach cancer in association with the consump-
tion of green tea, prospective studies (Tsubono et al, 2001;
Galanis et al, 1998) have not. In two Japanese studies, a decreased
risk of stomach cancer was associated with the highest level of
consumption of green tea (10 or more cups per day in one study
(Kono et al, 1988) and seven or more cups per day in the other
(Inoue et al, 1998)) but not with intermediate levels of consump-
tion. The present study aimed to examine prospectively the
association between the consumption of green tea and the risk of
stomach cancer death, while controlling potential confounders,
using data from the Japan Collaborative Cohort (JACC) Study, a
Japan-wide population-based prospective study. This is the ﬁrst
study to analyse prospectively the effects of the consumption of
10 or more cups of green tea per day.
MATERIALS AND METHODS
JACC study
The JACC Study, the Japan Collaborative Cohort Study for Evalua-
tion of Cancer Risk (sponsored by the Ministry of Education,
Science, Sports and Culture of Japan), is a nation-wide multicentre
prospective study to evaluate various risks on cancer incidence and
mortality. Study methods and ethical issues have been described in
detail elsewhere (Ohno et al, 2001; Aoki, 1996; Subcommittee of
ethical issues, 1996). Brieﬂy, our study was initiated in 1988 and
enrollment continued until the end of 1990. Subjects were followed
until the end of 1997 unless they had moved or developed one of
the prospectively deﬁned endpoints. Forty-ﬁve municipalities were
involved in this prospective study. They included six cities, 34
towns and ﬁve villages, which covered most of Japan. Enrollment
was drawn from participants in the general health checkups that
are periodically provided by Japanese municipalities. Because we
estimated 1000000 person-years of follow-up was necessary for
the detection of an association between mortality for cancer of
several sites common in Japan and various risk factors, we enrolled
127477 (54032 men and 73445 women) apparently healthy inha-
bitants after completion of a questionnaire. Two strategies were
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www.bjcancer.comapplied to obtain informed consent for participation; in the major-
ity of study areas, it was obtained with a signature on the cover
page of the questionnaire. In some study areas, it was obtained
at group level by explaining the aim of the study and conﬁdential-
ity of the data to the leader of the community (Yatsuya et al,
2002). The questionnaire was ﬁlled in by the participants at home
and checked by interviewers. Missing and unclear answers were
conﬁrmed or corrected by telephone.
The research protocol of the present study was approved by the
Ethics Committee of Medical Care and Research, University of
Occupational and Environmental Health, Kitakyushu, Japan.
Follow-up and identiﬁcation of stomach cancer cases
Our primary endpoints were death from any causes on December
31, 1997 (censored). Those who had moved address were also trea-
ted as censored. The mean follow-up period was 8.0 years for men
and 8.2 years for women.
A follow-up survey was conducted annually to verify the vital
status of participants. For deceased subjects, the cause of death
was obtained from the death certiﬁcate at the regional health
center, with the permission of the Ministry of Public Management,
Home Affairs, Post and Telecommunications. These data were
collected at the central ofﬁce of the Research Committee. Underly-
ing causes of death were determined by the Ministry of Health,
Labour and Welfare and coded according to the International Clas-
siﬁcation of Disease (9th revision: ICD-9) by the end of 1994 and
to ICD-10 from 1995. The stomach cancer codes were 151.0 to
151.9 of ICD-9 or C16.0 to c16.9 of ICD-10.
Subjects
Since questions on the daily consumption of green tea were not
included in the questionnaire in seven areas (four rural areas and
three urban/rural areas), we excluded those data (15609 men
and 19894 women). Of the 91974 remaining, the 6469 who were
under 40, and the 3115 who were 80 or over were excluded from
the analysis. Of the 82390 participants who were aged 40–79 years
(34173 men and 48217 women) at the time of enrollment, we
excluded those with a history of stomach cancer (n=216) and those
who were followed-up for 12 months or less (n=800). Of the
remaining 33 612 men and 47 762 women aged 40 to 79, 3242
men (9.6%) and 5281 women (11.1%) had green tea consumption
data missing from the questionnaire so these too were excluded.
The remaining 30 370 men and 42 481 women were included in
the present analysis (see Appendix I).
Questionnaire
The self-administered questionnaire on baseline characteristics
covered medical history and included lifestyle-related questions
such as diet, physical activity, drinking and smoking, occupation,
level of education, reproductive history (women only) and the
family history of several medical conditions including cancer. Mean
time spent ﬁlling out the questionnaire was 26.0 and 27.7 min for
men and women, respectively.
Questions on dietary habits included the consumption frequency
of food items/groups. Five frequency categories were determined
for consumption of most dietary products. In addition, the ques-
tionnaire asked for an individual’s preference for salty foods,
consumption of nonalcoholic beverages, smoking, and alcohol.
Information on the intake of energy and other nutrients was not
available in this study. The frequency of green tea consumption
was initially assessed from ﬁve possible answers, i.e., every day
(more than one cup per day), three to four cups per week, one
to two cups per week, one to two cups per month and seldom,
to the question: ‘Do you drink Japanese tea (green tea)?’ For those
who consumed tea every day, the number of cups a day was further
identiﬁed. We created ﬁve categories based on the answers to these
questions: less than one cup per day, one or two cups per day,
three or four cups per day, ﬁve to nine cups per day, and 10 or
more cups per day according to a previous prospective study
(Tsubono et al, 2001) for the purpose of compatibility. In Japan
the volume of a typical cup of green tea is 100–120 ml.
The validity of this food frequency questionnaire was evaluated
by comparing it with four 3-day dietary records (total weight) for
eight men and 77 women selected from the study areas. Spearman’s
correlation coefﬁcients for the frequencies were 0.41 for spinach
and other coloured vegetables, 0.45 for tomatoes and white vegeta-
bles, 0.35 for fruits, and 0.29 for green tea, while other foods
ranged between 0.1 and 0.8 (unpublished data).
Data processing
Cox proportional hazard regression analysis was used. The relative
risk (RR) and its 95% conﬁdence interval (CI) were calculated
based on the regression coefﬁcient and its standard error (Cox,
1972) for an indicator term corresponding to a level of indepen-
dent variable. For multivariate analysis, several factors were listed
as potential confounders according to epidemiological studies
(World Cancer Research Fund, 1997; Yatsuya et al, 2002; Hoshiya-
ma and Sasaba, 1992). The model always included age (four
categories: 40–49, 50–59, 60–69, 70–79). Trends of association
were assessed by the regression model assigning scores (0–4) to
the levels of the independent variable. Statistical signiﬁcance (two
sided) was based on the ratio of the regression coefﬁcient and its
standard error. Statistical analysis (PHREG procedure) was
performed by the Statistical Analysis System (SAS Institute, 1983).
RESULTS
Table 1 compares the characteristics of subjects according to green
tea consumption, which showed a similar pattern in men and
women. A history of peptic ulcer differed by green tea consump-
tion in both men and women as examined by the Mantel-
Haenszel chi-square test for trends (P50.01), being higher among
those who consumed less green tea. The proportions of smokers
were higher among those who consumed more green tea for both
men (P50.01) and women (P50.05). Men and women with a
higher intake of green tea also tended to consume rice, miso soup,
green-yellow vegetables, white vegetables and fruit more frequently.
Table 2 shows relative risk (RR) of stomach cancer and its 95%
conﬁdence interval (CI) according to green tea consumption, and
P-value for trends. The age-adjusted relative risk of male subjects
drinking one or two cups per day and 10 or more cups per day
showed 2.3 (95% CI: 1.4–3.8) and 1.8 (95% CI: 1.0–3.0);
however, after adjustment for certain dietary elements, history of
peptic ulcer and family history of stomach cancer as potential
confounders; this association was not statistically signiﬁcant. No
dose-response effect from heavier green tea consumption was
observed (P for trend 40.05). Multivariate RRs were closer to
age-adjusted and age- and smoking adjusted RRs in women. The
exclusion of deaths from stomach cancer identiﬁed in the ﬁrst 35
months of follow-up did not alter the ﬁndings (data not shown).
The association in the multivariate models between these poten-
tial confounders and stomach cancer was not statistically signiﬁcant
except for a family history of stomach cancer (RRs were 1.5 (95%
CI: 1.0–2.3) for men and 2.6 (95% CI: 2.6–4.3) for women).
DISCUSSION
This study is the largest prospective study to investigate green tea
consumption and the risk of stomach cancer death. Among possi-
ble limitations of the present study was incomplete data. About
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British Journal of Cancer (2002) 87(3), 309–313 ã 2002 Cancer Research UK10% of subjects were excluded from analysis because they had not
given information concerning their daily consumption of green tea
and the effects of such exclusion are unknown. Nevertheless, there
was no difference between the percentages of smokers in the
excluded data (51.3% in men and 5.6% in women) and those in
the included data (53.1% and 5.4% respectively) examined by
E
p
i
d
e
m
i
o
l
o
g
y
Table 2 Relative risk of stomach cancer death according to green tea consumption
Green tea consumption (cups per day)
P for
51 1 or 2 3 or 4 5 to 9 510 trend
Men
Number of deaths from stomach cancer 24 51 51 76 38
Person-months of follow-up 472478 437045 683263 904435 352384
Age-adjusted RR 1.0 2.3 (1.4–3.8) 1.3 (0.8–2.1) 1.4 (0.9–2.3) 1.8 (1.0–3.0) 0.417
Age- and smoking status adjusted RR 1.0 2.2 (1.3–3.7) 1.2 (0.7–2.1) 1.4 (0.9–2.3) 1.7 (1.0–3.1) 0.408
Multivariate RR* 1.0 1.6 (0.9–2.9) 1.1 (0.6–1.9) 1.1 (0.6–1.9) 1.0 (0.5–2.0) 0.634
Women
Number of deaths from stomach cancer 20 18 40 32 9
Person-months of follow-up 791277 531587 1046736 1307787 347069
Age-adjusted RR 1.0 1.3 (0.7–2.5) 1.3 (0.7–2.3) 0.8 (0.4–1.5) 0.9 (0.4–1.9) 0.390
Age and smoking status adjusted RR 1.0 1.2 (0.6–2.4) 1.1 (0.6–1.9) 0.7 (0.4–1.4) 0.8 (0.3–1.6) 0.257
Multivariate RR* 1.0 1.1 (0.5–2.5) 1.0 (0.5–2.1) 0.8 (0.4–1.6) 0.7 (0.3–2.0) 0.476
*Adjusted for age (four classes), smoking status (never, past, current), history of peptic ulcer, family history of stomach cacner, consumption of rice, miso soup, green-yellow
vegetables, white vegetables, fruits, and preference for salty foods (two categories: see Table 1). Values in parentheses are 95 per cent conﬁdence intervals.
Table 1 Characteristics of the subjects according to green-tea consumption
Green tea consumption (cups per day)
51 1 or 2 3 or 4 5 to 9 510 Total P for trend*
Men
Age class
40–49 n=7807 19.6 19.8 25.2 27.0 8.4 100.0 –
50–59 n=8923 16.5 14.3 22.9 32.7 13.6 100.0 –
60–69 n=9396 14.8 13.0 23.9 34.2 14.2 100.0 –
70–79 n=4244 14.9 14.3 25.0 33.4 12.5 100.0 –
History of peptic ulcer (%) 23.9 22.2 22.5 21.2 23.0 22.3 0.004
Family history of stomach cancer (%)# 11.5 10.9 11.6 12.4 13.3 11.9 0.001
Smoking (%)
Current 50.8 54.8 51.8 53.1 56.3 53.1 0.000
Past 26.0 25.6 27.5 26.7 25.7 26.5 0.617
Daily dietary consumption (%)
Rice (54 bowls/day) 40.5 38.8 40.4 48.0 51.4 43.9 0.000
Miso soup (51 cup/day) 71.0 67.5 69.9 74.6 77.5 72.1 0.000
Preference for salty foods (yes) 40.9 41.9 41.8 42.5 44.5 42.2 0.002
Green-yellow vegetables (51/day) 30.4 32.2 32.5 35.9 39.7 34.0 0.000
White vegetables (51/day) 25.3 27.9 27.6 28.7 31.2 28.0 0.000
Fruits (53/week) 23.1 28.3 28.2 29.2 31.7 28.1 0.000
Women
Age class
40–49 n=10243 22.7 17.2 25.7 27.5 6.9 100.0 –
50–59 n=12964 19.5 12.2 25.6 33.6 9.1 100.0 –
60–69 n=13466 18.8 11.4 25.6 34.8 9.3 100.0 –
70–79 n=5808 16.7 12.0 29.0 33.5 8.8 100.0 –
History of peptic ulcer (%) 13.5 11.7 12.0 10.6 10.2 11.6 0.000
Family history of stomach cancer (%) 12.9 13.1 12.7 13.0 14.4 13.0 0.216
Smoking (%)
Current 6.2 6.3 4.8 4.8 7.0 5.5 0.023
Past 1.7 1.5 1.5 1.5 1.9 1.6 0.887
Daily dietary consumption (%)
Rice (54 bowls/day) 18.1 16.3 19.1 20.9 20.5 19.2 0.000
Miso soup (51 cup/day) 64.5 62.4 63.3 67.9 72.5 65.7 0.000
Preference for salty foods (yes) 25.8 25.5 25.5 26.9 32.4 26.6 0.000
Green-yellow vegetables (51/day) 38.9 40.7 41.6 44.4 48.5 42.4 0.000
White vegetables (51/day) 38.6 37.0 36.9 38.6 42.1 38.2 0.013
Fruits (53/week) 37.9 45.2 43.8 45.6 52.4 44.2 0.000
*Mantel-Haenszel chi-square test; #We deﬁned a positive family history of stomach cancer as when the subject had at least one ﬁrst-degree relative (parents or siblings) with a
history of stomach cancer.
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respectively). The missing information seemed to occur randomly.
If drinking green tea, widely consumed in Japan and other Asian
countries, protects against stomach cancer, it would be an inexpen-
sive and convenient method of primary prevention. Another
prospective study also found no association between green tea
and stomach cancer (Tsubono et al, 2001). Little other evidence
is available from prospective studies (Galanis et al, 1998). In the
present study, we showed that high consumption of green tea
(4=10 cups per day) was not associated with the risk of stomach
cancer death based on multivariate analysis. We also showed that
those with a higher intake of green tea also tended to consume rice,
miso soup, green-yellow vegetables, white vegetables and fruits
more frequently, and that a higher proportion of current smokers
also consumed green tea more frequently. Another strong poten-
tially limiting factor is the possibility of general over-reporting
since subjects consuming 10 or more cups of green tea per day also
reported consuming more of every item asked. If it were so, the
effects of high consumption of green tea would be masked by
misclassiﬁcation. However, green tea consumption did not show
a dose-response relationship and any preventive effects of green
tea might not be substantial after adjustments for several potential
confounders.
In general, ﬁndings from case-control studies often conﬂict with
those from prospective studies (Bushman, 1998; World Cancer
Research Fund, 1997; Blot et al, 1996). In these retrospective
studies, some patients with stomach cancer might have decreased
their consumption of green tea before the diagnosis because of
their abdominal symptoms. This change in practice might have
biased their recall of past intake in such a way that they underes-
timated their true consumption, resulting in spurious inverse
associations (Tsubono et al, 2001). We agree that such bias could
partly explain the inconsistent results seen between different study
designs.
In Japan, tea is usually made in china pots with hot water
(about 808C) and not only are the ﬁrst extracts consumed, but also
the second and/or the third as well. The effective components of
green tea such as polyphenols might be insufﬁcient in the second
and/or third extracts. If high consumption of green tea (4=10
cups per day) were protective against stomach cancer, the Japanese
custom of drinking second/third extracts would be less effective in
the prevention of stomach cancer.
Another possible limitation was that we did not obtain informa-
tion on the presence or absence of a history of infection with
Helicobacter pylori, a strong risk factor for stomach cancer (Asaka
et al, 1997). The subjects with chronic gastritis caused by H. pylori
infection might have limited their consumption of green tea. If so,
the prevalence of infection would have been lower in the subjects with
higher intakes of green tea. If not, it is unlikely that the prevalence of
infection is higher among the subjects with a high consumption of
green tea. Thus, we believe that not considering H. pylori infection
would not have masked an inverse association between the risk of
stomach cancer death and the consumption of green tea.
In summary, we found no inverse association between the
consumption of green tea and the risk of stomach cancer death
in Japan in a prospective cohort study.
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Appendix I Process to identify subjects in the present study
Men Women Total
At enrolment 54032 73445 127477
No questions 15609 19894 35503
Subtotal 38423 53551 91974
Under 39 years of age 2967 3502 6469
80 or over years of age 1283 1832 3115
Subtotal 34173 48217 82390
History of stomach cancer 144 72 216
Subtotal 34029 48145 82174
Follow-up for less than or equal to 12 months 417 383 800
Subtotal 33612 47762 81374
Missing data 3242 5281 8523
Total 30370 42481 72851
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